• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza virus activity in the world, 3 February 2012 (WHO, edited): A(H5N1) clade 2.3.4.2 in China, A(H1N1)pdm09 in Mexico

Giuseppe

Emeritus
[Source: World Health Organization, full page: (LINK).]

Influenza virus activity in the world, 3 February 2012



Source: Laboratory confirmed data from the Global Influenza Surveillance and Response System (GISRS).



Based on FluNet reporting (as of 31 January 2012, 13:35 UTC), during weeks 2 to 3 (8 ? 21 January 2012), National Influenza Centres (NICs) and other national influenza laboratories from 84 countries, areas or territories reported data.

The WHO GISRS laboratories tested more than 31292 specimens.

4709 were positive for influenza viruses, of which 3633 (77.2%) were typed as influenza A and 1076 (22.8%) as influenza B.

Of the sub-typed influenza A viruses, 668 (22.9%) were influenza A(H1N1)pdm09 and 2250 (77.1%) were influenza A(H3N2).

Of the characterized B viruses, 90 (33.5%) belong to the B-Yamagata lineage and 179 (66.5%) to the B-Victoria lineage.



Summary

During weeks 2 and 3 in 2012, laboratory confirmed influenza activity continued to increase in many countries in the northern hemisphere but in general influenza activity remained mild.

Globally influenza A(H3N2) continued to be the predominant virus subtype detected.

In general, influenza A(H1N1)pdm09 and B activity was low, except for Mexico with A(H1N1)pdm09 predominating and for some Asian countries with B as main circulating virus type.

Both B/Yamagata and B/Victoria lineage viruses co-circulated, the majority of viruses detected belong to the B/Victoria lineage.

In Europe, the Middle East, North Africa and North America, influenza A(H3N2) activity continued to increase in many countries with localized to widespread activity reported.

Influenza B virus was detected at low levels with A(H1N1)pdm09 detected sporadically in general.

In Asia, influenza activity of A(H3N2) and B viruses continued to increase in many countries, with B viruses predominating in China and China Hong Kong Special Administrative Region, and A(H3N2) viruses in many other countries. Influenza A(H1N1)pdm09 was detected at low levels.

In the southern hemisphere, influenza activity remained low. Among sporadic detections, the majority are influenza A(H3N2) viruses.

A human case of influenza A(H5N1) virus infection was reported in China. The virus belongs to clade 2.3.4.2, and is expected to be sensitive to NAIs and adamantanes by sequencing.

Further analysis of the virus including its antigenic relationship with developed candidate reassortant vaccine viruses is being conducted by the WHO Collaborating Centre for Reference and Research on Influenza at the Chinese Center for Disease Control and Prevention.


Other analyses
-
------
 
Back
Top Bottom